Rockefeller Capital Management L.P. Vanda Pharmaceuticals Inc. Transaction History

Rockefeller Capital Management L.P.

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 02, 2022	SELL	$9.44 - $11.76 $292 - $364	-31 Reduced 43.66%	40 $0
Q2 2022 Aug 12, 2022	SELL	$9.31 - $11.84 $484 - $615	-52 Reduced 42.28%	71 $0
Q1 2022 May 13, 2022	SELL	$10.84 - $16.55 $6,298 - $9,615	-581 Reduced 82.53%	123 $1,000
Q4 2021 Feb 14, 2022	BUY	$15.69 - $21.14 $7,907 - $10,654	504 Added 252.0%	704 $11,000
Q2 2021 Aug 10, 2021	BUY	$15.71 - $21.51 $3,142 - $4,302	200 New	200 $4,000
Q1 2021 May 11, 2021	SELL	$13.42 - $20.28 $6,710 - $10,140	-500 Closed	0 $0
Q3 2020 Nov 13, 2020	SELL	$9.32 - $12.02 $549 - $709	-59 Reduced 10.55%	500 $4,000
Q2 2020 Aug 12, 2020	SELL	$9.66 - $12.02 $1,052 - $1,310	-109 Reduced 16.32%	559 $6,000
Q4 2019 Feb 07, 2020	BUY	$12.38 - $17.47 $1,646 - $2,323	133 Added 24.86%	668 $11,000
Q3 2019 Nov 12, 2019	SELL	$12.27 - $15.79 $429 - $552	-35 Reduced 6.14%	535 $7,000
Q2 2019 Aug 09, 2019	SELL	$13.37 - $18.85 $4,946 - $6,974	-370 Reduced 39.36%	570 $8,000
Q1 2019 May 10, 2019	BUY	$17.59 - $31.05 $16,534 - $29,187	940 New	940 $17,000

161

45.2M

165K

33.6K

Ticker VNDA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 56,561,500
Market Cap $264M
Description
Vanda Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of therapies to address high unmet medical needs. The company's marketed products include HETLIOZ for the treatment of non-24-hour sleep-wake disorders; and Fanapt oral tablets for the treatment of schizophrenia. Its products under developme...

Get notified when there are updates to the investment portfolio of Rockefeller Capital Management L.P., based on Form 13F filings with the SEC.

Stay updated on Rockefeller Capital Management L.P. with notifications on news.